|
1
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Ward EM, Johnson CJ, Cronin KA,
Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, et al:
Annual report to the nation on the status of cancer, 1975-2014,
featuring survival. J Natl Cancer Inst. 109:djx0302017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng R, Qu C, Zhang S, Zeng H, Sun K, Gu
X, Xia C, Yang Z, Li H, Wei W, et al: Liver cancer incidence and
mortality in China: Temporal trends and projections to 2030. Chin J
Cancer Res. 30:571–579. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sia D, Villanueva A, Friedman SL and
Llovet JM: Liver cancer cell of origin, molecular class, and
effects on patient prognosis. Gastroenterology. 152:745–761. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Idilman R, De Maria N, Colantoni A and Van
Thiel DH: Pathogenesis of hepatitis B and C-induced hepatocellular
carcinoma. J Viral Hepat. 5:285–299. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kanwal F, Kramer JR, Duan Z, Yu X, White D
and El-Serag HB: Trends in the burden of nonalcoholic fatty liver
disease in a united states cohort of veterans. Clin Gastroenterol
Hepatol. 14:301–8.e1-e2. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgan TR, Mandayam S and Jamal MM:
Alcohol and hepatocellular carcinoma. Gastroenterology. 127((5
Suppl 1)): S87–S96. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pan Z, Choi S, Ouadid-Ahidouch H, Yang JM,
Beattie JH and Korichneva I: Zinc transporters and dysregulated
channels in cancers. Front Biosci (Landmark Ed). 22:623–643. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ho E and Ames BN: Low intracellular zinc
induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA
binding, and affects DNA repair in a rat glioma cell line. Proc
Natl Acad Sci USA. 99:16770–16775. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vallee BL and Falchuk KH: The biochemical
basis of zinc physiology. Physiol Rev. 73:79–118. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Andreini C, Banci L, Bertini I and Rosato
A: Counting the zinc-proteins encoded in the human genome. J
Proteome Res. 5:196–201. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang L and Tepaamorndech S: The SLC30
family of zinc transporters-a review of current understanding of
their biological and pathophysiological roles. Mol Aspects Med.
34:548–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jeong J and Eide DJ: The SLC39 family of
zinc transporters. Mol Aspects Med. 34:612–619. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Costello LC and Franklin RB: The clinical
relevance of the metabolism of prostate cancer; zinc and tumor
suppression: Connecting the dots. Mol Cancer. 5:172006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu L, Hou Y, Hu J, Zhou L, Chen K, Yang X
and Song Z: SLC39A8/Zinc suppresses the progression of clear cell
renal cell carcinoma. Front Oncol. 11:6519212021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu L, Yang J and Wang C: Analysis of the
prognostic significance of solute carrier (SLC) family 39 genes in
breast cancer. Biosci Rep. 40:BSR202007642020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mas VR, Maluf DG, Archer KJ, Yanek K, Kong
X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P and Fisher
R: Genes involved in viral carcinogenesis and tumor initiation in
hepatitis C virus-induced hepatocellular carcinoma. Mol Med.
15:85–94. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen X, Cheung ST, So S, Fan ST, Barry C,
Higgins J, Lai KM, Ji J, Dudoit S, Ng IO, et al: Gene expression
patterns in human liver cancers. Mol Biol Cell. 13:1929–1939. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roessler S, Jia HL, Budhu A, Forgues M, Ye
QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX and Wang XW: A
unique metastasis gene signature enables prediction of tumor
relapse in early-stage hepatocellular carcinoma patients. Cancer
Res. 70:10202–10212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen P, Yao Y, Yang N, Gong L, Kong Y and
Wu A: Circular RNA circCTNNA1 promotes colorectal cancer
progression by sponging miR-149-5p and regulating FOXM1 expression.
Cell Death Dis. 11:5572020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Workman P, Aboagye EO, Balkwill F, Balmain
A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DA,
Glennie MJ, et al: Guidelines for the welfare and use of animals in
cancer research. Br J Cancer. 102:1555–1577. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang JC, Sun W, Khare P, Karimi M, Wang X,
Shen Y, Ober RJ and Ward ES: Engineering a HER2-specific
antibody-drug conjugate to increase lysosomal delivery and
therapeutic efficacy. Nat Biotechnol. 37:523–526. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao H, Guo Y, Li B, Li X, Wang Y, Han S,
Cheng D and Shuai X: M2-like tumor-associated macrophage-targeted
codelivery of STAT6 inhibitor and IKKβ siRNA induces M2-to-M1
repolarization for cancer immunotherapy with low immune side
effects. ACS Cent Sci. 6:1208–1222. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Wilhelm J, Li W, Li S, Wang Z,
Huang G, Wang J, Tang H, Khorsandi S, Sun Z, et al:
Polycarbonate-based ultra-pH sensitive nanoparticles improve
therapeutic window. Nat Commun. 11:58282020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chongsathidkiet P, Jackson C, Koyama S,
Loebel F, Cui X, Farber SH, Woroniecka K, Elsamadicy AA, Dechant
CA, Kemeny HR, et al: Sequestration of T cells in bone marrow in
the setting of glioblastoma and other intracranial tumors. Nat Med.
24:1459–1468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu YL, Ding CL, Qian CL, Qi ZT and Wang W:
Retinoid acid induced 16 deficiency aggravates colitis and
colitis-associated tumorigenesis in mice. Cell Death Dis.
10:9582019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiu P and Sheng J: A two-stage procedure
for comparing hazard rate functions. J R Statist Soc B. 70:191–208.
2008.
|
|
30
|
Moh MC, Lee LH, Yang X and Shen S: HEPN1,
a novel gene that is frequently down-regulated in hepatocellular
carcinoma, suppresses cell growth and induces apoptosis in HepG2
cells. J Hepatol. 39:580–586. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Notas G, Kolios G, Mastrodimou N, Kampa M,
Vasilaki A, Xidakis C, Castanas E, Thermos K and Kouroumalis E:
Cortistatin production by HepG2 human hepatocellular carcinoma cell
line and distribution of somatostatin receptors. J Hepatol.
40:792–798. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu JM, Xu Y, Skill NJ, Sheng H, Zhao Z, Yu
M, Saxena R and Maluccio MA: Autotaxin expression and its
connection with the TNF-alpha-NF-kappaB axis in human
hepatocellular carcinoma. Mol Cancer. 9:712010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang Y, Yan W, He X, Zhang L, Li C, Huang
H, Nace G, Geller DA, Lin J and Tsung A: miR-375 inhibits autophagy
and reduces viability of hepatocellular carcinoma cells under
hypoxic conditions. Gastroenterology. 143:177–187.e8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prieto-Domínguez N, Ordóñez R, Fernández
A, Méndez-Blanco C, Baulies A, Garcia-Ruiz C, Fernández-Checa JC,
Mauriz JL and González-Gallego J: Melatonin-induced increase in
sensitivity of human hepatocellular carcinoma cells to sorafenib is
associated with reactive oxygen species production and mitophagy. J
Pineal Res. 61:396–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jaffe JD, Wang Y, Chan HM, Zhang J,
Huether R, Kryukov GV, Bhang HE, Taylor JE, Hu M, Englund NP, et
al: Global chromatin profiling reveals NSD2 mutations in pediatric
acute lymphoblastic leukemia. Nat Genet. 45:1386–1391. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ghandi M, Huang FW, Jané-Valbuena J,
Kryukov GV, Lo CC, McDonald ER III, Barretina J, Gelfand ET,
Bielski CM, Li H, et al: Next-generation characterization of the
cancer cell line encyclopedia. Nature. 569:503–508. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li H, Ning S, Ghandi M, Kryukov GV, Gopal
S, Deik A, Souza A, Pierce K, Keskula P, Hernandez D, et al: The
landscape of cancer cell line metabolism. Nat Med. 25:850–860.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nusinow DP, Szpyt J, Ghandi M, Rose CM,
McDonald ER III, Kalocsay M, Jané-Valbuena J, Gelfand E, Schweppe
DK, Jedrychowski M, et al: Quantitative proteomics of the cancer
cell line encyclopedia. Cell. 180:387–402.e16. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Perz JF, Armstrong GL, Farrington LA,
Hutin YJF and Bell BP: The contributions of hepatitis B virus and
hepatitis C virus infections to cirrhosis and primary liver cancer
worldwide. J Hepatol. 45:529–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hartke J, Johnson M and Ghabril M: The
diagnosis and treatment of hepatocellular carcinoma. Semin Diagn
Pathol. 34:153–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ayuso C, Rimola J, Vilana R, Burrel M,
Darnell A, García-Criado Á, Bianchi L, Belmonte E, Caparroz C,
Barrufet M, et al: Diagnosis and staging of hepatocellular
carcinoma (HCC): Current guidelines. Eur J Radiol. 101:72–81. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Piñero F, Dirchwolf M and Pessôa MG:
Biomarkers in hepatocellular carcinoma: Diagnosis, prognosis and
treatment response assessment. Cells. 9:13702020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Chowdhury MMH, Salazar CJJ and Nurunnabi
M: Recent advances in bionanomaterials for liver cancer diagnosis
and treatment. Biomater Sci. 9:4821–4842. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Fukada T, Yamasaki S, Nishida K, Murakami
M and Hirano T: Zinc homeostasis and signaling in health and
diseases: Zinc signaling. J Biol Inorg Chem. 16:1123–1134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kolenko V, Teper E, Kutikov A and Uzzo R:
Zinc and zinc transporters in prostate carcinogenesis. Nat Rev
Urol. 10:219–226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Bafaro E, Liu Y, Xu Y and Dempski RE: The
emerging role of zinc transporters in cellular homeostasis and
cancer. Signal Transduct Target Ther. 2:170292017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Eide DJ: The SLC39 family of metal ion
transporters. Pflugers Arch. 447:796–800. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Schweigel-Röntgen M: The families of zinc
(SLC30 and SLC39) and copper (SLC31) transporters. Curr Top Membr.
73:321–355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Grattan BJ and Freake HC: Zinc and cancer:
Implications for LIV-1 in breast cancer. Nutrients. 4:648–675.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Taylor KM, Morgan HE, Smart K, Zahari NM,
Pumford S, Ellis IO, Robertson JF and Nicholson RI: The emerging
role of the LIV-1 subfamily of zinc transporters in breast cancer.
Mol Med. 13:396–406. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Unno J, Satoh K, Hirota M, Kanno A, Hamada
S, Ito H, Masamune A, Tsukamoto N, Motoi F, Egawa S, et al: LIV-1
enhances the aggressive phenotype through the induction of
epithelial to mesenchymal transition in human pancreatic carcinoma
cells. Int J Oncol. 35:813–821. 2009.PubMed/NCBI
|
|
53
|
Zhao L, Chen W, Taylor KM, Cai B and Li X:
LIV-1 suppression inhibits HeLa cell invasion by targeting
ERK1/2-Snail/Slug pathway. Biochem Biophys Res Commun. 363:82–88.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Wu C, Li D, Jia W, Hu Z, Zhou Y, Yu D,
Tong T, Wang M, Lin D, Qiao Y, et al: Genome-wide association study
identifies common variants in SLC39A6 associated with length of
survival in esophageal squamous-cell carcinoma. Nat Genet.
45:632–638. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Cui XB, Shen YY, Jin TT, Li S, Li TT,
Zhang SM, Peng H, Liu CX, Li SG, Yang L, et al: SLC39A6: A
potential target for diagnosis and therapy of esophageal carcinoma.
J Transl Med. 13:3212015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lian J, Jing Y, Dong Q, Huan L, Chen D,
Bao C, Wang Q, Zhao F, Li J, Yao M, et al: miR-192, a prognostic
indicator, targets the SLC39A6/SNAIL pathway to reduce tumor
metastasis in human hepatocellular carcinoma. Oncotarget.
7:2672–2683. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Ge Y, Mu W, Ba Q, Li J, Jiang Y, Xia Q and
Wang H: Hepatocellular carcinoma-derived exosomes in organotropic
metastasis, recurrence and early diagnosis application. Cancer
Lett. 477:41–48. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Subbotin VM: Privileged portal metastasis
of hepatocellular carcinoma in light of the coevolution of a
visceral portal system and liver in the chordate lineage: A search
for therapeutic targets. Drug Discov Today. 23:548–564. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Chandler P, Kochupurakkal BS, Alam S,
Richardson AL, Soybel DI and Kelleher SL: Subtype-specific
accumulation of intracellular zinc pools is associated with the
malignant phenotype in breast cancer. Mol Cancer. 15:22016.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hogstrand C, Kille P, Ackland ML, Hiscox S
and Taylor KM: A mechanism for epithelial-mesenchymal transition
and anoikis resistance in breast cancer triggered by zinc channel
ZIP6 and STAT3 (signal transducer and activator of transcription
3). Biochem J. 455:229–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Unno J, Masamune A, Hamada S and
Shimosegawa T: The zinc transporter LIV-1 is a novel regulator of
stemness in pancreatic cancer cells. Scand J Gastroenterol.
49:215–221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Wan X, Kong Z, Chu K, Yi C, Hu J, Qin R,
Zhao C, Fu F, Wu H, Li Y and Huang Y: Co-expression analysis
revealed PTCH1-3′UTR promoted cell migration and invasion by
activating miR-101-3p/SLC39A6 axis in non-small cell lung cancer:
Implicating the novel function of PTCH1. Oncotarget. 9:4798–4813.
2018. View Article : Google Scholar : PubMed/NCBI
|
